Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
870
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Adverse reactions to inactivated COVID-19 vaccination in patients with chronic liver disease: The effect of anxiety

Li Lva Department of Infectious Diseases, Taizhou Hospital, Zhejiang University, Linhai, Zhejiang, ChinaORCID Iconhttps://orcid.org/0000-0002-2132-6558View further author information
ORCID Icon,
Xiao-Qing Linb Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, ChinaView further author information
,
Yan Chenb Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, ChinaView further author information
,
He-Dan Chena Department of Infectious Diseases, Taizhou Hospital, Zhejiang University, Linhai, Zhejiang, ChinaView further author information
,
Mei-Xian Zhangc Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, ChinaView further author information
,
Hui Shaob Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, ChinaCorrespondence[email protected]
View further author information
,
Tao-Hsin Tungc Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, ChinaView further author information
&
Jian-Sheng Zhua Department of Infectious Diseases, Taizhou Hospital, Zhejiang University, Linhai, Zhejiang, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2136435 | Received 05 Aug 2022, Accepted 10 Oct 2022, Published online: 26 Oct 2022

References

  • Wu Q, Dudley MZ, Chen X, Bai X, Dong K, Zhuang T, Salmon D, Yu H. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med. 2021;19(1):1. doi:10.1186/s12916-021-02059-5.
  • Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385–5. doi:10.1016/j.jhep.2014.08.010.
  • Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, Pose E, Brenner EJ, Cargill T, Catana MA, Dhanasekaran R. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021;74(3):567–77. doi:10.1016/j.jhep.2020.09.024.
  • Kochhar S, Salmon DA. Planning for COVID-19 vaccines safety surveillance. Vaccine. 2020;38(40):6194–98. doi:10.1016/j.vaccine.2020.07.013.
  • Stefan M, Dlouhy P, Bezdickova L. [Vaccination against COVID-19]. Klin Mikrobiol Infekc Lek. 2021;27:49–60.
  • Sharma A, Patnaik I, Kumar A, Gupta R. COVID-19 vaccines in patients with chronic liver disease. J Clin Exp Hepatol. 2021;11(6):720–26. doi:10.1016/j.jceh.2021.06.013.
  • Wang J, Hou Z, Liu J, Gu Y, Wu Y, Chen Z, Ji J, Diao S, Qiu Y, Zou S, Zhang A. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study. J Hepatol. 2021;75(2):439–41. doi:10.1016/j.jhep.2021.04.026.
  • John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D, Labrada M, Baracco G, Dahman B. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021;181(10):1306–14. doi:10.1001/jamainternmed.2021.4325.
  • Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, et al. American association for the study of liver diseases expert panel consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease. Hepatology. 2021;74(2):1049–64. doi:10.1002/hep.31751.
  • Thuluvath PJ, Robarts P, Chauhan M. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. J Hepatol. 2021;75(6):1434–39. doi:10.1016/j.jhep.2021.08.008.
  • Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021;74(4):944–51. doi:10.1016/j.jhep.2021.01.032.
  • Asadi-Pooya AA, Barzegar Z, Sadeghian S, Nezafat A, Shahisavandi M, Nabavizadeh SA. COVID-19 vaccine hesitancy among patients with epilepsy or other chronic conditions. Disaster Med Public Health Prep. 2021:1–3. doi:10.1017/dmp.2021.311.
  • Suragh TA, Lamprianou S, MacDonald NE, Loharikar AR, Balakrishnan MR, Benes O, Hyde TB, McNeil MM. Cluster anxiety-related adverse events following immunization (AEFI): an assessment of reports detected in social media and those identified using an online search engine. Vaccine. 2018;36(40):5949–54. doi:10.1016/j.vaccine.2018.08.064.
  • Loharikar A, Suragh TA, MacDonald NE, Loharikar A, Suragh TA, MacDonald NE, Balakrishnan MR, Benes O, Lamprianou S, Hyde TB, et al. Anxiety-related adverse events following immunization (AEFI): a systematic review of published clusters of illness. Vaccine. 2018;36(2):299–305. doi:10.1016/j.vaccine.2017.11.017.
  • Hause AM, Gee J, Johnson T, Jazwa A, Marquez P, Miller E, Su J, Shimabukuro TT, Shay DK. Anxiety-related adverse event clusters after Janssen COVID-19 vaccination - five U.S. mass vaccination sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(18):685–88. doi:10.15585/mmwr.mm7018e3.
  • Gianfredi V, Minerva M, Casu G, Capraro M, Chiecca G, Gaetti G, Mazzocchi RM, Musarò P, Basteri P, Bertini B, et al. Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects. Acta Biomed. 2021;92(S6):e2021487. doi:10.23750/abm.v92iS6.12365.
  • Singh AK, Wagner AL, Joshi J, Carlson BF, Aneja S, Boulton ML. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience. Expert Rev Vaccines. 2018;17(6):555–62. doi:10.1080/14760584.2018.1484285.
  • McMurtry CM. Managing immunization stress-related response: a contributor to sustaining trust in vaccines. Can Commun Dis Rep. 2020;46(6):210–18. doi:10.4745/ccdr.v46i06a10.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.